Busting the breast cancer with astrazeneca's gefinitib
Breast cancer is the most common cancer diagnosed in women, and in 2020, there were 684, 996 deaths due to this disease. Epidermal growth factor receptors (EGFRs) and their respective ligands have been blamed for the pathogenesis and resistance to treatment in specific breast cancer cases. With EGFR...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley Open Access
2023
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/106928/1/Busting%20the%20breast%20cancer%20with%20astrazeneca%27s%20gefinitib.pdf |